Analysis Group HEOR Consultants to Present at ISPOR 2023
                        
                        
                        
                        
                        Event:ISPOR 2023
                            Dates: 
                            May 7–10, 2023
                            
                            Host:
                            ISPOR – The International Society for Pharmacoeconomics and Outcomes Research
                            
                            Location:
                            Boston, MA
                            
                    
Analysis Group, a global leader in health economics and outcomes research, will present a Forum session, two podium presentations, and 16 research posters at ISPOR 2023, which will be hosted at the Boston Convention & Exhibition Center in Boston, MA.
Managing Principal Noam Kirson, Past President of the ISPOR Boston Regional Chapter, will moderate the Forum “Generalized Cost Effectiveness Analysis – From Theory to Practice” with affiliated expert Lou Garrison (The Comparative Health Outcomes, Policy, and Economics [CHOICE] Institute) as well as Patricia Synnott (Center for the Evaluation of Value and Risk in Health), Jon Campbell (Institute for Clinical and Economic Review), and Chris Leibman (Biogen). In addition to providing an overview of recent theoretical and practical extensions to traditional cost-effectiveness analyses (CEAs) and their implications for value assessment, the panelists will also discuss challenges and opportunities in the implementation of generalized cost-effectiveness analysis (GCEA) methods in practice, including the generalized risk-adjusted cost-effectiveness (GRACE) framework, real option value, life cycle pricing, and various societal dimensions of value.
Further details on the Forum, podium presentations, and poster presentations are available in our ISPOR 2023 Presentation Guide and on ISPOR’s website.
